Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

EMA recommends 11 drugs for approval in May meeting
BioPharma Dive
Thu, 05/25/17 - 09:26 am
Tags:
EMA, Europe, Sanofi, AstraZeneca, LEO Pharma, Novartis, Pfizer
Pfizer's Epogen biosim scores solid backing from FDA staff ahead of panel review
Fierce Pharma
Wed, 05/24/17 - 10:51 am
Tags:
Pfizer, Epogen, biosimilars, FDA, advisory panels, Amgen, anemia
Pfizer bows first Ibrance TV spot as Novartis revs up with rival breast cancer med Kisqali
Fierce Pharma
Wed, 05/24/17 - 10:37 am
Tags:
Pfizer, Ibrance, Novartis, breast cancer, drug ads
Astellas, Pfizer scrap a PhIII breast cancer study using Xtandi; New $30M fund will back Israeli biotech startups
Endpoints
Sat, 05/20/17 - 12:50 pm
Tags:
Astellas, Pfizer, breast cancer, clinical trials, Xtandi, Israel, biotech
Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic
Fierce Biotech
Fri, 05/19/17 - 10:19 am
Tags:
Iterum, antibiotics, Pfizer, clinical trials, sulopenem
ASCO: Lilly's abemaciclib vs. Pfizer's Ibrance? Too early to make a call, analysts say
Fierce Pharma
Thu, 05/18/17 - 08:00 pm
Tags:
ASCO 2017, Eli Lilly, Pfizer, abemaciclib, Ibrance, breast cancer
The top 15 generic drugmakers by 2016 revenue
Fierce Pharma
Wed, 05/17/17 - 09:39 am
Tags:
generics, Teva Pharmaceutical, Mylan Labs, Novartis, Pfizer, Allergan
Here's Why the Best Is Yet to Come for Pfizer Inc.
Motley Fool
Mon, 05/15/17 - 08:59 am
Tags:
Pfizer, Eucrisa, Xtandi, Inflectra
Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal
Endpoints
Thu, 05/11/17 - 11:21 am
Tags:
Pfizer, gene therapy, hemophilia, Sangamo BioSciences, SB-525, hemophilia A
Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town
Fierce Pharma
Wed, 05/10/17 - 09:31 am
Tags:
Pfizer, Merck KGaA, AstraZeneca, Bavencio, avelumab, bladder cancer, Imfinzi, FDA, Opdivo, Tecentriq
Pfizer collaborates to improve access to injectable contraceptive
Drug Delivery Business News
Tue, 05/9/17 - 10:25 am
Tags:
Pfizer, contraceptives, injectable contraceptives
FDA’s Ruling on Generic ZITHROMAX 180-Day Exclusivity: A Little Something for Everyone!
FDA Law Blog
Mon, 05/8/17 - 11:32 am
Tags:
FDA, generics, Zithromax, exclusivity, Pfizer, Lupin, antibiotics
Pfizer, awaiting a final NICE verdict, doles out free Ibrance in the U.K.
Fierce Pharma
Sun, 05/7/17 - 10:23 am
Tags:
Pfizer, Ibrance, NICE, UK, breast cancer
Merck vs. Pfizer: Which Stock Looks Better Post-Earnings?
Yahoo/Zacks.com
Sun, 05/7/17 - 10:16 am
Tags:
Merck, Pfizer, earnings, drug stocks
Pfizer making progress on Hospira manufacturing issues, execs say
BioPharma Dive
Fri, 05/5/17 - 10:15 am
Tags:
Pfizer, Hospira, drug manufacturing
With Pfizer’s Xtandi sales slowing, analysts question $14B Medivation price
Fierce Pharma
Wed, 05/3/17 - 02:15 pm
Tags:
Pfizer, Xtandi, Medivation
So what’s holding back Pfizer and Gilead from the really big M&A deals we’ve all been waiting for?
Endpoints
Wed, 05/3/17 - 10:54 am
Tags:
Pfizer, Gilead Sciences, M&A
Is Pfizer really weighing a BMS buy? Clues from Q1's earnings call say it just may be
Fierce Pharma
Wed, 05/3/17 - 10:09 am
Tags:
Pfizer, earnings, M&A, Bristol-Myers Squibb
3 Reasons Pfizer, Inc. Investors Shouldn't Be Concerned About the Q1 Revenue Dip
Motley Fool
Wed, 05/3/17 - 10:08 am
Tags:
Pfizer, earnings
Pfizer beats 1Q profit forecasts, but sales dip misses views
Yahoo/AP
Tue, 05/2/17 - 11:33 am
Tags:
Pfizer, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.